Ceramides

C4 Dihydroceramide is a biochemical assay reagent.

C6 Biotin glucosylceramide (d18:1/6:0) (C6 Glucosylceramide-biotin; N-Hexanoyl-biotin-glucosylceramide) is an ester product.

(±)-2'-hydroxy Ceramide (d18:0/18:0) is a sphingomyelin that can be isolated from mammalian platelets stimulation by ADP.

C8 Dihydroceramide is a negative control of C8 Ceramide. C8-Ceramide (N-Octanoyl-D-erythro-sphingosine) is a cell-permeable analog of naturally occurring ceramides. C8-Ceramide has anti-proliferation properties and acts as a potent chemotherapeutic agent. C8-Ceramide stimulates dendritic cells to promote T cell responses upon virus infections. C8-Ceramide induces slight activation of protein kinase (PKC) in vitro.

C18:1 Lactosyl(β) ceramide (d18:1/18:1) is a lipid that can be used to prepare lipid nanoparticles (LNPs) for drug delivery.

C18:1 Glucosyl(β) ceramide (d18:1/18:1(9Z)) is a lipid that can be used to prepare lipid nanoparticles (LNPs) for drug delivery.

C12 Glucosyl(β) ceramide (d18:1/12:0) is a lipid that can be used to prepare lipid nanoparticles (LNPs) for drug delivery.

C16 Ceramide (d14:1/16:0) is a ceramide.

C22 Dihydro 1-deoxyceramide (m18:0/22:0) is a ceramide.

C17 Dihydro ceramide (d18:0/17:0) is a sphosphingolipid.

1-Deoxy-Cer is a Ceramide which is essential component of the skin permeability barrier.

CER1(d18:1/28:0/18:2) is a skin ceramide essential for maintaining skin barrier integrity and hydration.

C25 Ceramide (d18:1/25:0) is an endogenous ultra-long-chain ceramide that antagonizes the detrimental effects of long-chain ceramides on insulin sensitivity. C25 Ceramide (d18:1/25:0) is specifically enriched in oxidative skeletal muscle fibers, where it serves dual roles in providing structural support to cell membranes and regulating cellular signaling. By participating in the regulation of lipid homeostasis within muscle fibers, C25 Ceramide (d18:1/25:0) helps maintain normal insulin signaling. C25 Ceramide (d18:1/25:0) is primarily utilized in research concerning metabolic diseases—particularly in mechanistic studies investigating the muscle fiber type-specific aspects of insulin resistance.

C24:1 Mono-sulfo Galactosyl (β) ceramide (d18:1/24:1) (ammonium) is a glycosphingolipid.

C16 Ceramide (Cer) (d18:1(14Z)/16:0) is a sphingosine ceramide composed of long-chain sphingosine (d18:1) and palmitic acid (C16:0). It is one of the key lipid signaling molecules involved in apoptosis signaling. C16 ceramides are particularly involved in cell cycle arrest, cell death, and insulin signaling inhibition.

EOP (t18:0/30:0/18:2) (C48:2 EOP (t18:0/30:0w18:2 (9Z,12Z)); N-(30-Linoleoyloxy-triacontanoyl)-phytosphingosine) is a plant ceramide-based EOS analog. EOP (t18:0/30:0/18:2) is formed by esterifying an ω-hydroxy very long chain ceramide (C28-36) with the essential fatty acid linoleic acid. EOP (t18:0/30:0/18:2) has been used as a component of a model stratum corneum lipid mixture.

C18:1 Galactosyl(β) ceramide (d18:1/18:1(9Z)) is a lipid that can be used to prepare lipid nanoparticles (LNPs) for drug delivery.

C6 Ceramide (d18:1/6:0) alkyne is an ω-alkyne derivative of C6 ceramide. The terminal alkyne group can be used in click chemistry reactions to tag C6 ceramide with fluorescent or biotinylated labels, allowing the analysis of the metabolism and biological activity of C6 ceramide.

C24:1 Mono-sulfo Galactosyl (α) ceramide (d18:1/24:1) (ammonium) is a glycosphingolipid.

C8 L-threo ceramide (d18:1/8:0) (N-Octanoyl-L-threo-sphingosine) is an ester product.